1,627
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Co-delivery of honokiol, a constituent of Magnolia species, in a self-microemulsifying drug delivery system for improved oral transport of lipophilic sirolimus

, , , , , , , & show all
Pages 2513-2523 | Received 19 Dec 2014, Accepted 12 Feb 2015, Published online: 02 Apr 2015

References

  • Ambudkar SV, Dey S, Hrycyna CA, et al. (1999). Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 39:361–98
  • Anton N, Benoit JP, Saulnier P. (2008). Design and production of nanoparticles formulated from nano-emulsion templates-a review. J Control Release 128:185–99
  • Anuchapreeda S, Leechanachai P, Smith MM, et al. (2002). Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem Pharmacol 64:573–82
  • Avtanski DB, Nagalingam A, Bonner MY, et al. (2014). Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis. Mol Oncol 8:565–80
  • Basalious EB, Shawky N, Badr-Eldin SM. (2010). SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization. Int J Pharm 391:203–11
  • Bouchemal K, Briancon S, Perrier E, Fessi H. (2004). Nano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimisation. Int J Pharm 280:241–51
  • Chaudhary PM, Roninson IB. (1993). Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J Natl Cancer Inst 85:632–9
  • Collnot EM, Baldes C, Wempe MF, et al. (2006). Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers. J Control Release 111:35–40
  • Cummins CL, Salphati L, Reid MJ, Benet LZ. (2003). In vivo modulation of intestinal CYP3A metabolism by P-glycoprotein: studies using the rat single-pass intestinal perfusion model. J Pharmacol Exp Ther 305:306–14
  • Dahan A, Amidon GL. (2009). Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs. 6:19–28
  • Di YM, Li CG, Xue CC, Zhou SF. (2008). Clinical drugs that interact with St. John's wort and implication in drug development. Curr Pharm Design 14:1723–42
  • Dokania S, Joshi AK. (2014). Self-microemulsifying drug delivery system (SMEDDS) - challenges and road ahead. Drug Deliv. Early Online: 1-16. DOI: 10.3109/10717544.2014.896058
  • Ershov FI, Kas'ianova NV, Vasil'ev AN. (2002). Kaletra (lopinavir/ritonavir) -- a new HIV protease inhibitor. Antibiot Khimioter 47:27–9
  • Esumi T, Makado G, Zhai H, et al. (2004). Efficient synthesis and structure-activity relationship of honokiol, a neurotrophic biphenyl-type neolignan. Bioorg Med Chem Lett 14:2621–5
  • Friche E, Jensen PB, Sehested M, et al. (1990). The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor. Cancer Commun 2:297–303
  • Gaylord G. (1999). New Norvir soft-gel capsule formulation approved by FDA. Posit Living 8:11
  • Gershanik T, Benita S. (2000). Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm 50:179–88
  • Gursoy N, Garrigue JS, Razafindratsita A, et al. (2003). Excipient effects on in vitro cytotoxicity of a novel paclitaxel self-emulsifying drug delivery system. J Pharm Sci 92:2411–18
  • Gursoy RN, Benita S. (2004). Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother 58:173–82
  • Herzog CE, Tsokos M, Bates SE, Fojo AT. (1993). Increased mdr-1/P-glycoprotein expression after treatment of human colon carcinoma cells with P-glycoprotein antagonists. J Biol Chem 268:2946–52
  • Hintzen F, Perera G, Hauptstein S, et al. (2014). In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin. Int J Pharm 472:20–6
  • Houghton P, Fang R, Techatanawat I, et al. (2007). The sulphorhodamine (SRB) assay and other approaches to testing plant extracts and derived compounds for activities related to reputed anticancer activity. Methods 42:377–87
  • Juliano C, Cossu M, Alamanni MC, Piu L. (2005). Antioxidant activity of gamma-oryzanol: mechanism of action and its effect on oxidative stability of pharmaceutical oils. Int J Pharm 299:146–54
  • Kang BK, Lee JS, Chon SK, et al. (2004). Development of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int J Pharm 274:65–73
  • Lei Y, Qi J, Nie S, et al. (2012). Solid self-nanoemulsifying cyclosporine A pellets prepared by fluid-bed coating: stability and bioavailability study. J Biomed Nanotechnol 8:515–21
  • Li W, Wang Q, Su Q, et al. (2014). Honokiol suppresses renal cancer cells' metastasis via dual-blocking epithelial-mesenchymal transition and cancer stem cell properties through modulating miR-141/ZEB2 signaling. Mol Cells 37:383–8
  • Li X, Yuan Q, Huang Y, et al. (2010). Development of silymarin self-microemulsifying drug delivery system with enhanced oral bioavailability. AAPS PharmSciTech 11:672–8
  • Limtrakul P, Anuchapreeda S, Buddhasukh D. (2004). Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids. BMC Cancer 4:13
  • Lin JH, Yamazaki M. (2003). Clinical relevance of P-glycoprotein in drug therapy. Drug Metab Rev 35:417–54
  • Lundin PD, Bojrup M, Ljusberg-Wahren H, et al. (1997). Enhancing effects of monohexanoin and two other medium-chain glyceride vehicles on intestinal absorption of desmopressin (dDAVP). J Pharmacol Exp Ther 282:585–90
  • Patel SSP, Patel NM, Patel MM. (2010). A self-microemulsifying drug delivery system (SMEDDS). Int J Pharm Sci Res 4:29–35
  • Ma L, Chen J, Wang X, et al. (2011). Structural modification of honokiol, a biphenyl occurring in Magnolia officinalis: the evaluation of honokiol analogues as inhibitors of angiogenesis and for their cytotoxicity and structure-activity relationship. J Med Chem 54:6469–81
  • Mekjaruskul C, Yang YT, Leed MG, et al. (2013). Novel formulation strategies for enhancing oral delivery of methoxyflavones in Kaempferia parviflora by SMEDDS or complexation with 2-hydroxypropyl-beta-cyclodextrin. Int J Pharm 445:1–11
  • Mu L, Elbayoumi TA, Torchilin VP. (2005). Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin. Int J Pharm 306:142–9
  • Muller C, Bailly JD, Goubin F, et al. (1994). Verapamil decreases P-glycoprotein expression in multidrug-resistant human leukemic cell lines. Int J Cancer 56:749–54
  • Pouton CW, Porter CJ. (2008). Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev 60:625–37
  • Rege BD, Kao JP, Polli JE. (2002). Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur J Pharm Sci 16:237–46
  • Sachan KK, Kasture SB. (2010). Self-emulsifying drug delivery system a novel approach for enhancement of bioavailability. Int J Pharm Tech Res 2:1738–45
  • Sonneveld P, Wiemer E. (1997). Inhibitors of multidrug resistance. Curr Opin Oncol 9:543–8
  • Sun M, Zhai X, Xue K, et al. (2011). Intestinal absorption and intestinal lymphatic transport of sirolimus from self-microemulsifying drug delivery systems assessed using the single-pass intestinal perfusion (SPIP) technique and a chylomicron flow blocking approach: linear correlation with oral bioavailabilities in rats. Eur J Pharm Sci 43:132–40
  • Tsai SK, Huang CH, Huang SS, et al. (1999). Antiarrhythmic effect of magnolol and honokiol during acute phase of coronary occlusion in anesthetized rats: influence of L-NAME and aspirin. Pharmacology 59:227–33
  • Wahlang B, Pawar YB, Bansal AK. (2011). Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model. Eur J Pharm Biopharm 77:275–82
  • Xu D, Lu Q, Hu X. (2006). Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol. Cancer Lett 243:274–80
  • Yamagata T, Kusuhara H, Morishita M, et al. (2007). Effect of excipients on breast cancer resistance protein substrate uptake activity. J Control Release 124:1–5
  • Yee S. (1997). In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man- fact or myth. Pharm Res 14:763–6
  • Yin YM, Cui FD, Mu CF, et al. (2009). Docetaxel microemulsion for enhanced oral bioavailability: preparation and in vitro and in vivo evaluation. J Control Release 140:86–94
  • Yoo JH, Shanmugam S, Thapa P, et al. (2010). Novel self-nanoemulsifying drug delivery system for enhanced solubility and dissolution of lutein. Arch Pharmacal Res 33:417–26
  • Zeng Z, Zhou G, Wang X, et al. (2010). Preparation, characterization and relative bioavailability of oral elemene o/w microemulsion. Int J Nanomed 5:567–72
  • Zhang Y, Li X, Zhou Y, et al. (2010). Cyclosporin A-loaded poly(ethylene glycol)-b-poly(d,l-lactic acid) micelles: preparation, in vitro and in vivo characterization and transport mechanism across the intestinal barrier. Mol Pharm 7:1169–82
  • Zhang Z, Chen Y, Deng J, et al. (2014). Solid dispersion of berberine-phospholipid complex/TPGS 1000/SiO(2): preparation, characterization and in vivo studies. Int J Pharm 465:306–16
  • Zhao C, Liu ZQ. (2011). Comparison of antioxidant abilities of magnolol and honokiol to scavenge radicals and to protect DNA. Biochimie 93:1755–60

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.